OBJECTIVE: This study was designed to:[1] measure, for the first time, metastin (kisspeptin)
levels in women with polycystic ovary syndrome (PCOS), a condition associated with …

Objective The aim of the present study was to evaluate serum concentrations of metastin in
relation with hormonal and metabolic profile in patients with and without polycystic ovary …

OBJECTIVE: This study was designed to: STUDY DESIGN: The study was a clinical study.
Nineteen adolescent women with PCOS, twenty-three adult women with the syndrome, and …

Aim: To investigate association of kisspeptin levels in infertile women with different ovarian
reserve patterns. Materials and methods: In this prospective cross-sectional study, 157 …

Objective: Due to the complex relationship between kisspeptin and the hypothalamic-
pituitary-gonadal axis, the study was planned to measure the kisspeptin levels in polycystic …

Background. Kisspeptin is a neuropeptide that upregulates gonadotropin‐releasing
hormone (GnRH) secretion. It is an essential element for the luteinizing hormone (LH) surge …

Kisspeptins, including metastin, are encoded by the KiSS-1 gene and play an important role
in regulating the hypothalamic gonadotropin-releasing hormone (GnRH) system via G …

Kisspeptin has been shown to participate in the regulation of pituitary hormone secretion
and energy metabolism. In PCOS patients, there are disorders in pituitary hormone secretion …

Polycystic ovary syndrome (PCOS) affects 6% to 20% of reproductive age women and is the
most frequent cause of anovulatory infertility. Its physiopathology may result in part from …

Objectives: To compare plasma kisspeptin, serum leptin, and serum retinol-binding protein 4
(RBP4) levels in women with and without polycystic ovary syndrome (PCOS) and to …